Recursion Pharma Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
Rating: 1.201513875
Author: Trendlyne DVM scores

Momentum Trap

about

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improvi...

4.44 -0.24 (-5.13%)

64.08% Fall from 52W High

31.1M

XNAS Volume

XNAS 18 Dec, 2025 4:30 PM (EST)

Low Financial Strength

22.2 / 100

Expensive Valuation

13.2 / 100

Technically Neutral

38.5 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 58%

7 analysts

Recursion Pharma Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Recursion Pharma Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improvi...

64.08% Fall from 52W High

SWOT Analysis

Recursion Pharma Inc (Class A) Live Price Chart